$PULM

Pulmatrix (PULM) Q2 Revenue Falls 100%

Pulmatrix ( NASDAQ:PULM ) , a biotechnology company known for its dry powder inhalation delivery platform iSPERSE™, released its second quarter results on August 6, 2025, covering the quarter that ended June 30, 2025. Pulmatrix reported zero revenue for the period ended June 30, 2025.

Original reporting
Motley Fool · JesterAI
Published Aug 7, 2025, 1:58 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2025, 3:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Pulmatrix (PULM) Q2 Revenue Falls 100% — source image
Decision brief

The 30-second read

$PULMBearishLow
01

Why it matters

The revenue drop could signal underlying issues affecting product development or commercialization.

02

Market read

The news is highly relevant for biotech investors and traders focusing on Pulmatrix and similar companies.

03

What to watch

Company may have significant cash reserves or partnerships that mitigate financial impact.

Timing: short-term (immediate reaction possible within days)

Background

Pulmatrix specializes in inhalation delivery platforms; recent revenue collapse suggests operational or developmental setbacks.

Company-level read

Ticker impact

$PULMBearishHigh confidence
Context

Primary focus due to the news about revenue decline.

Expected impact

Potential short-term decline; long-term impact uncertain without additional context.

Evidence & confidence

The revenue drop is a factual, quantifiable event with immediate market implications, especially for a biotech company with limited revenue streams.

Market effects

Biotech sector may face increased scrutiny and volatility.

Limited regional impact; primarily affects US biotech stocks.

Low; specific to US biotech sector.

Counterpoint

The revenue decline may be due to one-time factors or strategic restructuring, potentially leading to future recovery.

Key entities

  • Pulmatrix Inc.

    Biotech firm focusing on inhalation delivery platforms.

  • JesterAI

    Author of the news article.

Related articles

$MDTMed

Jury Orders Medtronic to Pay $88 Million After Finding Surgeons Were Not Adequately Warned About a Hernia Mesh

A federal jury ordered Medtronic’s Covidien unit to pay $88 million to Larry and Tammy Patterson after finding surgeons were not adequately warned about risks of Covidien’s Symbotex hernia mesh. The Aug. 4 verdict followed a three-week trial in Massachusetts. Jurors awarded $77 million to Larry and $11 million for loss of consortium, with no punitive damages.

$LMTMedAI 8/10

What is Patriot missile system, why its supplies are down

The article explains the U.S.-made Patriot mobile air defense system and why interceptor missile supplies are down. It cites Raytheon and Lockheed for system details and notes CSIS estimates about 65% of U.S. interceptors were expended Feb to July, leaving under 850. It says the U.S. approved 5,250 interceptors for Gulf states and awarded Lockheed a contract up to $58.6B.

$ETNMed

Eaton Gains on $7-Million Contract

Eaton (NYSE:ETN) said the U.S. Air Force Research Laboratory awarded it a $7 million, 24-month contract to use quantum computing, machine learning, and advanced visualization to improve power grid resilience and protection. The work, with Infleqtion and Penn State, targets detection and response to multiple concurrent physical and cyber threats, addressing NERC N-2 contingency requirements.

$XOMMed

ExxonMobil awards McDermott engineering work for Rovuma LNG

ExxonMobil Moçambique Limitada issued McDermott Energy Solutions (UK) a letter of intent for limited engineering and procurement work on Rovuma LNG Phase 1 midstream development. The award supports planning ahead of a final investment decision expected in 2026. Rovuma LNG targets 12 modular trains totaling 18.6 mtpa, with start-up in 2031. ExxonMobil says the 30-year project could generate about $150B in revenues for Mozambique’s government.

$ESLTMed

Serbia to open joint UAV factory with Elbit in September

Serbia President Aleksandar Vucic said Serbia will open a joint UAV factory with Elbit Systems, with inauguration expected Sept 15-20. Elbit will hold 51% and Serbia’s state arms firm SDPR 49%. The factory relates to a five-year contract covering precision rockets and unmanned systems, plus ISTAR, digitization and upgrades.

$NOCMed

The Pentagon is urging defense contractors to urgently ramp up weapons production – WP

The U.S. Department of Defense, according to The Washington Post, asked defense contractors to submit within 21 days production and delivery schedules for critical systems, citing depleted stockpiles. CSIS estimates cite heavy early use of missiles and falling Patriot and THAAD inventories. The Pentagon is working with Northrop Grumman and Lockheed Martin, including a $58.6B deal to triple PAC-3 output by 2030, pending a stalled $1.15T defense budget.